Panion & BF Biotech Inc (1760) — Cash Flow Quality Index
Panion & BF Biotech Inc (1760) has a Cash Flow Quality Index of 0.70x as of September 2025. Operating cash flow of NT$73.31 Million is below net income of NT$104.58 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore 1760 asset base for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Panion & BF Biotech Inc Cash Flow Quality Index (2009–2024)
Historical Cash Flow Quality Index for Panion & BF Biotech Inc across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Panion & BF Biotech Inc tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Panion & BF Biotech Inc (2009–2024)
Year-by-year earnings quality comparison for Panion & BF Biotech Inc. For live market cap and the full company financial profile, see 1760 market cap.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.62x | NT$351.19 Million | NT$217.44 Million | ▼ -29.7% |
| 2023 | 2.30x | NT$177.42 Million | NT$77.22 Million | ▼ -14.5% |
| 2022 | 2.69x | NT$489.87 Million | NT$182.34 Million | ▲ +22.3% |
| 2021 | 2.20x | NT$401.23 Million | NT$182.65 Million | ▲ +1449.3% |
| 2020 | -0.16x | NT$-14.55 Million | NT$89.41 Million | ▼ -140.5% |
| 2019 | 0.40x | NT$90.98 Million | NT$226.29 Million | ▲ +25.0% |
| 2018 | 0.32x | NT$78.58 Million | NT$244.38 Million | ▼ -59.6% |
| 2017 | 0.80x | NT$113.97 Million | NT$143.14 Million | ▼ -41.8% |
| 2016 | 1.37x | NT$177.22 Million | NT$129.42 Million | ▲ +172.9% |
| 2015 | 0.50x | NT$58.30 Million | NT$116.19 Million | ▼ -50.8% |
| 2014 | 1.02x | NT$76.11 Million | NT$74.57 Million | ▼ -72.5% |
| 2013 | 3.72x | NT$86.22 Million | NT$23.20 Million | ▼ -94.0% |
| 2009 | 62.08x | NT$76.98 Million | NT$1.24 Million | — |